Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), is pleased to announce that actor, author, former champion bodybuilder and World’s Strongest Man competitor, Franco Columbu, has joined the management team at Iso-Sport. Mr. Columbu will focus on the business development of Iso-Sport and raise further awareness of the Company’s health and wellness CBD products for athletes around the world.
Columbu has won every important title in bodybuilding and power lifting. He is a two-time Mr. Olympia − the most prestigious and lucrative title in bodybuilding − and has been Mr. Universe and Mr. World, among others. Even more amazing is the fact that he won his second Mr. Olympia at the age of 40, a mere five years after he had completely dislocated his knee in competition.
Some of his power lifting world records are even more legendary: Bench Press − 525 lbs., Squat − 655 lbs., and Dead Lift − 750 lbs. In April 1979, Franco even made it into the Guinness Book of World Records for the highest lung power when he was able to blow up a hot water bottle until it burst in just 55 seconds using only sheer lung power.
Franco Columbu’s film work includes producing and starring in “Beretta’s Island,” “Doublecross on Costa’s Island,” and “Ancient Warriors.” He also produced and directed “Sardinia, The Greatest Isle of the Sea,” an award-winning documentary about his homeland. Columbu appeared in the documentary, “Pumping Iron,” and played supporting roles in the blockbuster movies, “Conan the Barbarian” and “The Terminator.” On television, he was technical advisor for and appeared in the CBS-TV movie “Getting Physical.” He has also been featured in several national TV and print commercials as well as numerous guest appearances and television shows.
Columbu graduated from Chiropractic College in 1977 and has been the recipient of several honors and awards throughout the years including:
- Induction into the Italian American Sports Hall of Fame in 1983.
- Received a Certificate of Merit from the IFBB in 1985.
- Awarded the highest civilian honor of merit – the merit of Ufficiale – by Francesco Cossiga, the President of Italy, on August 25, 1988.
- Received the FBB Achievement Medal Award in October 2004.
- Inducted into the World Gym Hall of Fame in 2006.
- Received the Muscle Beach Hall of Fame Award in 2007.
- Received an award from the ICA for “Special service to the chiropractic profession and the world of fitness” in 2009.
Currently, Mr. Columbu serves as a consultant and advisor on many boards and organizations including the Arnold Sports Festival Event Committee, where he works with elite professional and amateur athletes alike.
With the recent addition of David Hawk and now Franco Columbu, Iso-Sport believes it has firmly positioned itself as a true leader and a driving force. “We’re so excited to have Franco Columbu join the Iso-Sport management team,” said Isodiol CEO, Marcos Agramont. “Franco’s career as a world-renowned bodybuilder, champion weightlifter, high-performance athlete, and chiropractor adds an unprecedented level of experience and credibility to the Iso-Sport brand as we continue our mission of bringing the finest CBD products to athletes around the world.”
Along with the announcement of Franco Columbu joining the management team, a recent partnership was forged that will bring Iso-Sport products to Powerhouse Gyms worldwide. The agreement marks one of the first times that CBD-based products are made available through a global fitness center chain. Additionally, the company has entered a partnership with training giant, ALTIS, to develop innovative CBD sports products for elite athletes while investigating the impact of these products on overall health and performance. That partnership is called the Iso-Sport Living Lab.
Read more about Franco Columbu and his partnership with Iso-Sport: https://iso-sport.com/franco-columbu.
View Iso-Sport products and learn about the company: https://iso-sport.com
About Isodiol International Inc.
Isodiol International Inc. is focused on the development of CBD-based pharmaceuticals and CBD consumer products. With a dedicated passion for the industry it serves, the company’s mission is to create a cultural movement by building awareness and social acceptance, ultimately empowering people to live better lives – globally. This mission is enacted through unique divisions and subsidiaries that help deliver the powerful benefits of CBD to people around the world.
Since its inception, Isodiol® has directed its efforts toward advancing CBD research, education, development, and manufacturing. The company has made tremendous strides in the CBD space through clinical research and forging valuable partnerships that have allowed the manufacturing of goods in accordance with strict industry practices and standards.
BSPG Laboratories™, a subsidiary of Isodiol®, was recently registered with the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) for producing CBD as an active pharmaceutical ingredient (API) for use in pharmaceutical applications for humans and animals.
Isodiol® is a publicly-traded entity with corporate offices based in Vancouver, Canada, and additional operations in the United States, South America, and the U.K. For more information about Isodiol®, please visit https://isodiol.com or call (855) 979-6751.
ON BEHALF OF THE BOARD
Marcos Agramont, CEO & Director
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future the Company’s business, its product offerings and plans for sales and marketing. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s products and plan will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims any obligation and does not intend, to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release.